High-dose intravitreal chemotherapy in the treatment of high-risk retinoblastoma

High-dose intravitreal chemotherapy in the treatment of high-risk retinoblastoma

Background: Intravitreal chemotherapy (IVitC; intravitreal cytostatic injections) is the most promising field of multiagent chemotherapy for retinoblastoma, and, when combined with systemic multiagent chemotherapy, enables maximum effects on the tumor. Purpose: To improve the method of primary co...

Full description

Bibliographic Details
Main Authors:	N. F. Bobrova, T. A. Sorochynska, S. A. Tronina, T. V. Romanova, O. Yu. Bratishko
Format:	Article
Language:	English
Published:	Ukrainian Society of Ophthalmologists 2022-08-01
Series:	Journal of Ophthalmology
Subjects:	retinoblastoma intravitreal chemotherapy combination chemotherapy children
Online Access:	https://www.ozhurnal.com/en/archive/2022/4/4-fulltext

Similar Items

Improving the ablastic capacity of intravitreal chemotherapy for retinoblastoma
by: N. F. Bobrova, et al.
Published: (2022-04-01)

Chemotherapy in Retinoblastoma: Current Approaches
by: Özge Yanık, et al.
Published: (2015-12-01)

Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma
by: Xiling Yu, et al.
Published: (2020-08-01)

Intravitreal chemotherapy in the management of retinoblastoma in a resource-limited setting
by: Kashmira Rawjee, et al.
Published: (2022-01-01)

The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model
by: Elham Delrish, et al.
Published: (2023-02-01)

Pushing the limit: Globe salvage of Group D retinoblastoma with severe vitreous seeding with intra-arterial chemotherapy and 15 cycles of intravitreal chemotherapy
by: Eugenia C. Greig, et al.
Published: (2024-03-01)

Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding
by: Alahmadi G, et al.
Published: (2023-06-01)

Changes in Treatment Patterns and Globe Salvage Rate of Advanced Retinoblastoma in Korea: Efficacy of Intra-Arterial Chemotherapy
by: Dong Hyun Lee, et al.
Published: (2021-11-01)

Ultrastructural changes in the rabbit retina after various one-time doses of intravitreal melphalan
by: N.F. Bobrova, et al.
Published: (2020-08-01)

Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras
by: David A Camp, et al.
Published: (2019-01-01)

Retinoblastoma: A comprehensive review
by: Adarsh S Naik, et al.
Published: (2016-01-01)

Treatment of Retinoblastoma: What Is the Latest and What Is the Future
by: Paula Schaiquevich, et al.
Published: (2022-04-01)

Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class—A Meta-Analysis
by: Anthony B. Daniels, et al.
Published: (2021-05-01)

The art of retinoblastoma management - Curable yet challenging
by: Fairooz P Manjandavida, et al.
Published: (2018-01-01)

The role of intravitreal chemotherapy for retinoblastoma
by: Fairooz P Manjandavida, et al.
Published: (2015-01-01)

Retinoblastoma: Achieving new standards with methods of chemotherapy
by: Swathi Kaliki, et al.
Published: (2015-01-01)

Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma
by: Yacoub A. Yousef, et al.
Published: (2021-07-01)

Pathologic comparisons of enucleated eyes with retinoblastoma after superselective ophthalmic arterial chemotherapy with or without intravenous chemotherapy
by: Xiu-Yu Zhu, et al.
Published: (2020-11-01)

Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients
by: Kang Xue, et al.
Published: (2019-02-01)

Advance in the chemotherapy resistance of retinoblastoma
by: Yi-Lin Yu, et al.
Published: (2023-10-01)

Sclero-conjunctival ischaemia secondary to intra-arterial chemotherapy for retinoblastoma
by: Lisa McAnena, et al.
Published: (2020-06-01)

Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis
by: Qiuying Chen, et al.
Published: (2018-04-01)

Intra-arterial chemotherapy for retinoblastoma: Our first experience in Indonesia
by: Prijo Sidipratomo, MD, PhD, et al.
Published: (2022-12-01)

Successful salvage intravenous chemotherapy after tandem selective ophthalmic artery infusion chemotherapy in bilateral retinoblastoma
by: Hyun J Kim, et al.
Published: (2020-01-01)

Strabismus management in retinoblastoma survivors
by: Babak Masoomian, et al.
Published: (2024-03-01)

Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma
by: Namita Kumari, et al.
Published: (2023-01-01)

Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma
by: Giancarlo Saal-Zapata, et al.
Published: (2021-06-01)

Retinoblastoma treatment over time: a review article
by: Hassan Asadigandomani, et al.
Published: (2023-07-01)

Intra-arterial chemotherapy in retinoblastoma – A paradigm change
by: Fairooz P Manjandavida, et al.
Published: (2019-01-01)

Use of intra-arterial chemotherapy for retinoblastoma:results of a survey
by: Nathalia Grigorovski, et al.
Published: (2014-08-01)

Prevalence of Hematotoxic Effect of Intravenous Chemotherapy among Retinoblastoma Population in Tertiary Hospital in Bandung, Indonesia
by: Jennifer Hadiman, et al.
Published: (2019-05-01)

Favourable Response to Chemotherapy in Ora-Located Intraocular Retinoblastoma Grade B, C, and D: A Case Series
by: Anne Susanty, et al.
Published: (2022-08-01)

Twenty-Year Retrospective Study of Post-Enucleation Chemotherapy in High-Risk Patients with Unilateral Retinoblastoma
by: Yoon Sunwoo, et al.
Published: (2022-12-01)

Giant retinal tear after intra-arterial chemotherapy for advanced unilateral retinoblastoma
by: Camila V. Ventura, et al.
Published: (2017-08-01)

Current Trends in the Management of Retinoblastoma
by: Hayyam Kıratlı, et al.
Published: (2014-09-01)

Metastatic retinoblastoma at presentation: Clinical presentation, treatment, and outcomes
by: Chandra L Kakarala, et al.
Published: (2023-01-01)

Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy
by: Yacoub A Yousef, et al.
Published: (2017-01-01)

Clinical patterns and outcomes of retinoblastoma in a tertiary care centre of a developing country
by: Muhammad Moin, et al.
Published: (2023-08-01)

Conservative treatment using laser diode and systemic chemotherapy for early‐stage bilateral retinoblastoma: A 14‐year prospective cohort study
by: Thi Anh Thu Phan, et al.
Published: (2024-01-01)

Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma
by: Haitham Hilal Al-Mahrouqi, et al.
Published: (2021-01-01)